USA • New York Stock Exchange • NYSE:ABBV • US00287Y1091
Taking everything into account, ABBV scores 5 out of 10 in our fundamental rating. ABBV was compared to 524 industry peers in the Biotechnology industry. While ABBV has a great profitability rating, there are quite some concerns on its financial health. ABBV has a decent growth rate and is not valued too expensively. ABBV also has an excellent dividend rating.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROIC | 15.64% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Altman-Z | 2.42 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.79 | ||
| Fwd PE | 15.49 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.19 | ||
| EV/EBITDA | 16.21 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.14% |
ChartMill assigns a fundamental rating of 5 / 10 to ABBV.
ChartMill assigns a valuation rating of 6 / 10 to ABBVIE INC (ABBV). This can be considered as Fairly Valued.
ABBVIE INC (ABBV) has a profitability rating of 7 / 10.
The Price/Earnings (PE) ratio for ABBVIE INC (ABBV) is 23.79 and the Price/Book (PB) ratio is -150.41.
The Earnings per Share (EPS) of ABBVIE INC (ABBV) is expected to grow by 0.09% in the next year.